235 related articles for article (PubMed ID: 30367149)
1. Forcing ATGL expression in hepatocarcinoma cells imposes glycolytic rewiring through PPAR-α/p300-mediated acetylation of p53.
Di Leo L; Vegliante R; Ciccarone F; Salvatori I; Scimeca M; Bonanno E; Sagnotta A; Grazi GL; Aquilano K; Ciriolo MR
Oncogene; 2019 Mar; 38(11):1860-1875. PubMed ID: 30367149
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA NEAT1-modulated abnormal lipolysis via ATGL drives hepatocellular carcinoma proliferation.
Liu X; Liang Y; Song R; Yang G; Han J; Lan Y; Pan S; Zhu M; Liu Y; Wang Y; Meng F; Cui Y; Wang J; Zhang B; Song X; Lu Z; Zheng T; Liu L
Mol Cancer; 2018 May; 17(1):90. PubMed ID: 29764424
[TBL] [Abstract][Full Text] [Related]
3. Targeting p300/CBP Attenuates Hepatocellular Carcinoma Progression through Epigenetic Regulation of Metabolism.
Cai LY; Chen SJ; Xiao SH; Sun QJ; Ding CH; Zheng BN; Zhu XY; Liu SQ; Yang F; Yang YX; Zhou B; Luo C; Zhang X; Xie WF
Cancer Res; 2021 Feb; 81(4):860-872. PubMed ID: 33361394
[TBL] [Abstract][Full Text] [Related]
4. ATGL promotes the proliferation of hepatocellular carcinoma cells via the p-AKT signaling pathway.
Liu M; Yu X; Lin L; Deng J; Wang K; Xia Y; Tang X; Hong H
J Biochem Mol Toxicol; 2019 Nov; 33(11):e22391. PubMed ID: 31476254
[TBL] [Abstract][Full Text] [Related]
5. Metabolic reprogramming enables hepatocarcinoma cells to efficiently adapt and survive to a nutrient-restricted microenvironment.
Cassim S; Raymond VA; Dehbidi-Assadzadeh L; Lapierre P; Bilodeau M
Cell Cycle; 2018; 17(7):903-916. PubMed ID: 29633904
[TBL] [Abstract][Full Text] [Related]
6. Nur77 suppresses hepatocellular carcinoma via switching glucose metabolism toward gluconeogenesis through attenuating phosphoenolpyruvate carboxykinase sumoylation.
Bian XL; Chen HZ; Yang PB; Li YP; Zhang FN; Zhang JY; Wang WJ; Zhao WX; Zhang S; Chen QT; Zheng Y; Sun XY; Wang XM; Chien KY; Wu Q
Nat Commun; 2017 Feb; 8():14420. PubMed ID: 28240261
[TBL] [Abstract][Full Text] [Related]
7. A GYS2/p53 Negative Feedback Loop Restricts Tumor Growth in HBV-Related Hepatocellular Carcinoma.
Chen SL; Zhang CZ; Liu LL; Lu SX; Pan YH; Wang CH; He YF; Lin CS; Yang X; Xie D; Yun JP
Cancer Res; 2019 Feb; 79(3):534-545. PubMed ID: 30584071
[TBL] [Abstract][Full Text] [Related]
8. Variant 1 of KIAA0101, overexpressed in hepatocellular carcinoma, prevents doxorubicin-induced apoptosis by inhibiting p53 activation.
Liu L; Chen X; Xie S; Zhang C; Qiu Z; Zhu F
Hepatology; 2012 Nov; 56(5):1760-9. PubMed ID: 22576474
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic silencing of BCL6B inactivates p53 signaling and causes human hepatocellular carcinoma cell resist to 5-FU.
Li X; Yu J; Brock MV; Tao Q; Herman JG; Liang P; Guo M
Oncotarget; 2015 May; 6(13):11547-60. PubMed ID: 25909168
[TBL] [Abstract][Full Text] [Related]
10. Wild-Type p53 Promotes Cancer Metabolic Switch by Inducing PUMA-Dependent Suppression of Oxidative Phosphorylation.
Kim J; Yu L; Chen W; Xu Y; Wu M; Todorova D; Tang Q; Feng B; Jiang L; He J; Chen G; Fu X; Xu Y
Cancer Cell; 2019 Feb; 35(2):191-203.e8. PubMed ID: 30712844
[TBL] [Abstract][Full Text] [Related]
11. Rapamycin regulates the proliferation of Huh7, a hepatocellular carcinoma cell line, by up-regulating p53 expression.
Kwon S; Jeon JS; Ahn C; Sung JS; Choi I
Biochem Biophys Res Commun; 2016 Oct; 479(1):74-9. PubMed ID: 27616194
[TBL] [Abstract][Full Text] [Related]
12. Gα12 gep oncogene deregulation of p53-responsive microRNAs promotes epithelial-mesenchymal transition of hepatocellular carcinoma.
Yang YM; Lee WH; Lee CG; An J; Kim ES; Kim SH; Lee SK; Lee CH; Dhanasekaran DN; Moon A; Hwang S; Lee SJ; Park JW; Kim KM; Kim SG
Oncogene; 2015 May; 34(22):2910-21. PubMed ID: 25065598
[TBL] [Abstract][Full Text] [Related]
13. Adipose triglyceride lipase is a major hepatic lipase that regulates triacylglycerol turnover and fatty acid signaling and partitioning.
Ong KT; Mashek MT; Bu SY; Greenberg AS; Mashek DG
Hepatology; 2011 Jan; 53(1):116-26. PubMed ID: 20967758
[TBL] [Abstract][Full Text] [Related]
14. Antitumor effects in hepatocarcinoma of isoform-selective inhibition of HDAC2.
Lee YH; Seo D; Choi KJ; Andersen JB; Won MA; Kitade M; Gómez-Quiroz LE; Judge AD; Marquardt JU; Raggi C; Conner EA; MacLachlan I; Factor VM; Thorgeirsson SS
Cancer Res; 2014 Sep; 74(17):4752-61. PubMed ID: 24958469
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of PCK1 Gene Antagonizes Hepatocellular Carcinoma Through the Activation of Gluconeogenesis and Suppression of Glycolysis Pathways.
Tang Y; Zhang Y; Wang C; Sun Z; Li L; Cheng S; Zhou W
Cell Physiol Biochem; 2018; 47(1):344-355. PubMed ID: 29768256
[TBL] [Abstract][Full Text] [Related]
16. Liver cancer cell lines distinctly mimic the metabolic gene expression pattern of the corresponding human tumours.
Nwosu ZC; Battello N; Rothley M; Piorońska W; Sitek B; Ebert MP; Hofmann U; Sleeman J; Wölfl S; Meyer C; Megger DA; Dooley S
J Exp Clin Cancer Res; 2018 Sep; 37(1):211. PubMed ID: 30176945
[TBL] [Abstract][Full Text] [Related]
17. Hints on ATGL implications in cancer: beyond bioenergetic clues.
Vegliante R; Di Leo L; Ciccarone F; Ciriolo MR
Cell Death Dis; 2018 Feb; 9(3):316. PubMed ID: 29472527
[TBL] [Abstract][Full Text] [Related]
18. miR-139-5p inhibits aerobic glycolysis, cell proliferation, migration, and invasion in hepatocellular carcinoma via a reciprocal regulatory interaction with ETS1.
Hua S; Lei L; Deng L; Weng X; Liu C; Qi X; Wang S; Zhang D; Zou X; Cao C; Liu L; Wu D
Oncogene; 2018 Mar; 37(12):1624-1636. PubMed ID: 29335523
[TBL] [Abstract][Full Text] [Related]
19. WP1130 increases doxorubicin sensitivity in hepatocellular carcinoma cells through usp9x-dependent p53 degradation.
Liu H; Chen W; Liang C; Chen BW; Zhi X; Zhang S; Zheng X; Bai X; Liang T
Cancer Lett; 2015 Jun; 361(2):218-25. PubMed ID: 25749422
[TBL] [Abstract][Full Text] [Related]
20. Hepatic ATGL mediates PPAR-α signaling and fatty acid channeling through an L-FABP independent mechanism.
Ong KT; Mashek MT; Davidson NO; Mashek DG
J Lipid Res; 2014 May; 55(5):808-15. PubMed ID: 24610891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
